William Cavanagh Insider Profile
4 Followers
William Cavanagh, Chief R&D Officer at Perspective Therapeutics, holds 27.69K shares in Perspective Therapeutics (Ticker: CATX). Most recently, William Cavanagh Bought 7,692 shares of Perspective Therapeutics on Oct 28, 2020 for an estimated value of $4.00K.
William Cavanagh's Trading History
| CATXPerspective Therapeutics | Oct 28, 2020 | Chief R&D Officer | Informative Buy | 4.00K | $26.11K | |
CATX Insider Shares: 27.69K (0.03%) | ||||||
You May Also Like
William Cavanagh insider profile FAQ
What is the percentage of profitable transactions made by William Cavanagh?
The percentage of profitable transactions made by William Cavanagh is 60%.
What is the average return per transaction made by William Cavanagh?
The average return per transaction made by William Cavanagh is 23.50%.
What stocks does William Cavanagh hold?
William Cavanagh holds: CATX stocks.
What was William Cavanagh’s latest transaction?
William Cavanagh’s latest transaction was an Informative Buy of $4.00K.
What was William Cavanagh's most profitable transaction?
William Cavanagh’s most profitable transaction was an Informative Buy of CATX stock on October 28, 2020. The return on the trade was 55.80%.
What is William Cavanagh's role in Perspective Therapeutics?
William Cavanagh's role in Perspective Therapeutics is Chief R&D Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
